50°F
weather icon Clear

FDA approves remdesivir to treat COVID-19

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.

The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

It had been authorized for use on an emergency basis since spring, and now becomes the first drug to win full Food and Drug Administration approval for treating COVID-19.

President Donald Trump received it when he was sickened earlier this month.

Veklury is approved for people at least 12 years old and weighing at least 88 pounds who are hospitalized for a coronavirus infection. For patients younger than 12, the FDA will still allow the drug’s use in certain cases under its previous emergency authorization.

The drug works by inhibiting a substance the virus uses to make copies of itself. Certain kidney and liver tests are required before starting patients on it to ensure it’s safe for them and to monitor for any possible side effects. And the label warns against using it with the malaria drug hydroxychloroquine because that can curb its effectiveness.

“We now have enough knowledge and a growing set of tools to help fight COVID-19,” Gilead’s chief medical officer, Dr. Merdad Parsey, said in a statement.

The drug is either approved or has temporary authorization in about 50 countries, he noted.

Its price has been controversial, given that no studies have found it improves survival. Last week, a large study led by the World Health Organization found the drug did not help hospitalized COVID-19 patients, but that study did not include a placebo group and was less rigorous than previous ones that found a benefit. The FDA’s approval statement noted that, besides the NIH-led one, two other studies found the drug beneficial.

Gilead charges $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries, and $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.

So far, only steroids such as dexamethasone have been shown to cut the risk of dying of COVID-19. The FDA also has given emergency authorization to using the blood of survivors, and two companies are seeking similar authorization for experimental antibody drugs.

Don't miss the big stories. Like us on Facebook.
THE LATEST
Mask up: Vaccine won’t end the US crisis right away

Despite the expected arrival of COVID-19 vaccines in just a few weeks, it could take several months — probably well into 2021 — before things get back to something close to normal in the U.S. and Americans can once again go to the movies, cheer at an NBA game or give Grandma a hug.

 
Michigan certifies Biden’s win over Trump

Michigan election officials on Monday certified Democrat Joe Biden’s 154,000-vote victory in the state amid President Donald Trump’s brazen attempts to subvert the results of the election.

GM to replace Takata air bags in 7M vehicles

General Motors will recall about 7 million big pickup trucks and SUVs worldwide to replace potentially dangerous Takata air bag inflators.

Co-founder of viral ALS Ice Bucket Challenge dies

A co-founder of the social media ALS ice bucket challenge, which has raised more than $200 million worldwide for Lou Gehrig’s disease research, died Sunday at the age of 37, according to the ALS Association.

 
AstraZeneca says COVID-19 vaccine ‘up to 90% effective’

AstraZeneca says trials show its coronavirus vaccine is up to 90% effective, giving hope they may soon have access to a vaccine easier to distribute than some of its rivals.

 
Los Angeles County restricts in-person dining as virus surges

Los Angeles County announced new coronavirus-related restrictions Sunday that will prohibit in-person dining for at least three weeks as cases rise at the start of the holiday season and officials statewide begged Californians to avoid traveling or gathering in groups for Thanksgiving.

Man arrested in deadly attack at Nebraska fast-food restaurant

The attack came days after he was arrested outside of the restaurant after allegedly using someone else’s Sonic app account to buy a total of $57 worth of hamburgers and corn dogs.